Immediate Impact
39 standout
Citing Papers
Current status and future trends of the global burden of MASLD
2024 Standout
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
2024 Standout
Works of Adam Allgood being referenced
A multicenter, randomized, double-blind, PLB-controlled trial of Galectin-3 inhibitor (GR-MD-02) in patients with NASH cirrhosis and portal hypertension
2018
Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Adam Allgood | 41 | 33 | 18 | 78 | 37 | 5 | 109 | |
| Jessica V. Brewer | 45 | 22 | 23 | 103 | 46 | 7 | 201 | |
| Mary A. Schubert | 15 | 26 | 3 | 41 | 12 | 6 | 106 | |
| S. Fruhauf | 144 | 52 | 3 | 200 | 75 | 5 | 248 | |
| Alexandra Fox | 27 | 5 | 10 | 28 | 52 | 10 | 184 | |
| Constance Avery‐Clark | 147 | 58 | 88 | 15 | 7 | 206 | ||
| John Woolmore | 17 | 13 | 16 | 50 | 3 | 10 | 233 | |
| Blake R. Miller | 16 | 31 | 12 | 12 | 7 | 5 | 233 | |
| Thomas M. Collins | 37 | 9 | 9 | 11 | 5 | 5 | 182 | |
| Carmine Turco | 7 | 11 | 10 | 18 | 6 | 12 | 165 | |
| Allison F. Vitonis | 41 | 16 | 12 | 28 | 4 | 6 | 199 |
All Works
Loading papers...